Repik Alexey

 

Alexei Repik will earn a couple of tens of millions of dollars in the US market

Business20.09.2018

R-Pharm and the Russian Venture Company invested $ 4 million in the American company Bonti, which develops drugs for aesthetic medicine, and will receive up to $ 20 million when it is sold to the Irish giant Allergan.

Alexey Repik owes the Ministry of Health 387 million rubles

Business07.09.2018

Veronika Skvortsova's office has already filed 16 lawsuits against the company R-Pharm.

FAS Russia suspected the Ministry of Health in collusion with the companies of Alexey Repik

Officials21.06.2018

Three antitrust cases have already been initiated against Alexey Repik's R-Pharm.

Alexey Repik continued expansion in the Russian market

Business14.06.2018

The businessman bought a plant of accelerators for radiation therapy in Dubna (Moscow region).

"R-farm" did not pay for tablets

Business01.06.2018

The company lost the dispute to Native.

Alexander Vinokurov seizes pharmacy business in Russia

Business18.05.2018

The son-in-law of Foreign Minister Sergei Lavrov and the raider in combination intend to reshape the pharmacy business in Russia in his favor.

Ministry of Health denies collusion with Alexei Repik

Officials03.04.2018

The Ministry of Health of the Russian Federation responded to suspicions of the Federal Antimonopoly Service (FAS) in collusion with R-Pharm. The department does not understand which part of the antimonopoly legislation was violated, and the FAS verification is called biased.

Competitors set on Alexei Repik FAS Russia

Business23.03.2018

Suddenly, the clear-sighted antimonopoly service suspected the Ministry of Health in unusually generous preferences for the company "R-Pharm."